A blog maintained by an investor in Immune Response Corporation now called Orchestra Therapeutics, Inc. (OCHTQ.PK). Immune Response BioPharma claims to now own the research and trial results from Immune Response and is attempting to market their findings through the Immune Response BioPharma name.
Tuesday, October 9, 2012
Immune Response
Over 2,500 people have viewed this blog since it was first created. Seems a lot of people are interested in the connection between Immune Response/Orchestra and Immune Response BioPharma.
No comments:
Post a Comment